Session Overview

The development of improved, innovative models for the detection of toxicity of drugs, chemicals, or chemicals in cosmetics is crucial to efficiently bring new products safely to market in a cost-effective and timely manner. In addition, improvement in models to detect toxicity may reduce the incidence of unexpected post-marketing toxicity and reduce or eliminate the need for animal testing.This session welcomes speakers looking to address this need with their research

Session Chair: Dr Phil Jeffrey

Honorary Professor

William Harvey Research Institute, Queen Mary University of London

VIEW PROFILE

KEYNOTE SPEAKER: DR GIANNI DAL NEGRO

HEAD OF COMPLEX IN VITRO SYSTEMS
GSK

Presentation Title: Industry translational thinking in the qualification of new complex in vitro models

Keynote Speaker: Dr Lorna Ewart

Head of Microphysiological Systems Centre of Excellence, Innovative Medicines at AstraZeneca

VIEW PROFILE

 

KEYNOTE SPEAKER: PROFESSOR MIKE PHILPOTT

Advances in Cell and Tissue Culture - Mike Philpott

PROFESSOR OF CUTANEOUS BIOLOGY
QUEEN MARY UNIVERSITY LONDON

Title:Next generation modelling of human skin glands and appendages

The Presenters

 

Dr Janire Saez Castano

 

PostDoctoral Research Associate

University of Cambridge

Title: 3D gut-on-a-chip models with integrated microfluidics

 

Dr William R Critchley

Research Fellow

University of Leeds

Title: A physiological 3D model of angiogenesis

Dr Dawn Walker

Senior Lecturer

University of Sheffield

Title: From crowds to cells - what we can learn from computational models of cell cultures

Jonathon Temple

PHD Student

University of Liverpool 

Title: Imaging of 3D cell culture: challenges and opportunities

Dr Parveen Sharma

Principal Investigator

University of Liverpool

Presentation Title: In vitro liver zonation of primary rat hepatocytes

Dr Bhumika Singh

CSO Kirkstall Ltd

Title: 3DbioNet: a Technology Touching Life network

REGISTER NOW